CreditAccess Grameen Ltd. makes a corporate announcement

The ₹425 crore private NCD issuance carries a 2-year tenor with a blended coupon rate of approximately 9.23%, aligning closely with the company's weighted average cost of borrowing (WACB) of ~9.3% reported in the Q1 FY27 financial results ^[1].

Issuance Details

• Total Amount: Rs 425 Crores raised via private placement in June 2026 across two tranches ^[2].
• Tranche 1 (Nuvama Arranged): Rs 325 Crores with a 2-year tenure and a fixed coupon of 9.25% per annum, payable quarterly ^[2].
• Tranche 2 (Bajaj Finance Bilateral): Rs 100 Crores with a 2-year tenure and a floating coupon of 9.15% per annum, payable monthly ^[2].

Comparison with Cost of Funds

• Weighted Average Cost of Borrowing (WACB): Management disclosed during the Q1 FY27 earnings call that the borrowing cost stands at approximately 9.3% (noted as starting the year around 9.2% and projected to average ~9.3% to 9.4% as the liability mix shifts) ^[1], matching the 9.2% exit rate reported at the close of FY26 ^[3].
• Spread Analysis: The 9.15% to 9.25% coupon range on the new NCDs is effectively flat to marginally below the prevailing WACB (~9.3%), indicating that long-term domestic institutional debt is being secured at or near the portfolio average cost.

Implication

The issuance successfully extends liability maturity profiles to support asset-liability management (ALM) without exerting upward pressure on overall borrowing costs ^[1]. Diversifying into domestic NCDs alongside foreign borrowings (DFIs/ECBs) reinforces the company's 2028 funding architecture goals while maintaining cost efficiency ^[2].

Verdict: Incremental Liquidity for Growth

The ₹425 crore private placement completed in June 2026 represents incremental liquidity to support loan book expansion, rather than debt earmarked for structural debt refinancing.

CreditAccess Grameen (CA Grameen) is under no operational obligation to raise debt to service near-term maturities. The company's organic loan recoveries of Rs 8,759.8 Crores in FY27 ^[4] comfortably cover its total FY27 principal debt repayments of Rs 7,505.8 Crores ^[4], generating a positive static liquidity gap of Rs 1,254.1 Crores ^[4] without relying on fresh borrowings. Management explicitly positions this transaction as a strategic effort to diversify domestic institutional liability channels and build toward its long-term funding architecture ^[5] while supporting guided full-year AUM growth of 20.0%–25.0% ^[6].

---

Transaction Structure & ALM Context

In June 2026 (Q1 FY27), CA Grameen issued ₹425 crore in senior, secured Non-Convertible Debentures (NCDs) via private placement across two distinct tranches ^[2]:

• Tranche 1 (Rs 325 Crores): Arranged by Nuvama Fixed Income Advisory; 2-year tenure maturing June 26, 2028; fixed coupon of 9.25% p.a. ^[2]. Investors included Sundaram Finance, Nuvama Wealth, Julius Baer Capital, Royal Sundaram General Insurance, and Vivriti Fixed Income Fund ^[2].
• Tranche 2 (Rs 100 Crores): Bilaterally placed with Bajaj Finance Limited; 2-year tenure maturing June 12, 2028; floating coupon of 9.15% p.a. (linked to SBI 3-Month MCLR + 90 bps) ^[2].

FY27 Asset-Liability Management (ALM) & Liquidity Profile

---

Strategic Implications

• Loan Book Expansion Support: CA Grameen’s AUM stood at Rs 30,319 Crores in Q1 FY27 (+16.4% YoY) ^[6], with Q1 disbursements reaching Rs 6,107 Crores ^[6]. Management has guided for 20.0%–25.0% AUM growth in FY27 ^[6]. The ₹425 crore injection directly supplements total Q1 FY27 drawdowns of Rs 5,009 Crores ^[4] to finance expansion across core Microfinance and growing Retail Finance segments (which reached 20.6% of AUM) ^[6].
• Liability Base Diversification: The transaction expanded domestic capital market relationships (adding insurance companies, non-banking financial companies, and wealth managers) ^[2], helping lower concentration risk across bank term loans and foreign currency borrowings (which stand at 24% of the liability mix) ^[5].
• Margin Accretion vs Cost of Funds: Issuing 2-year paper at 9.15%–9.25% ^[2] fits within the company's borrowing cost framework. Given CA Grameen's Net Interest Margin (NIM) of 14.4% ^[5] and Q1 FY27 annualized ROA of 5.9% / cross-cycle target ROA of 3.0%–4.0% ^[6], the incremental capital can be deployed into loan originations at accretive spreads.

---

Disclosure Limits & Caveats

• Proceeds Fungibility: In non-banking financial companies (NBFC-MFIs), capital raises are pooled into central treasury operations. While regulatory filings confirm standard general lending and business operation purposes ^[7] rather than debt-refinancing escrow conditions, cash flows remain fungible across disbursements and borrowing repayments.
• Floating Rate Risk: The Rs 100 Crore bilateral tranche is tied to a floating rate benchmark (SBI 3-Month MCLR + 90 bps) ^[8], introducing marginal interest rate sensitivity relative to the fixed-rate portion.

Verdict and Capital Structure Summary

CreditAccess Grameen Limited (CREDITACC) maintains a reported consolidated Debt-to-Equity ratio of 3.01x (and 3.04x under SEBI Regulation 52(4) disclosures) as of Q1 FY27 (June 30, 2026) following its recent debenture issuances ^[9]. While the company's board approved substantial fundraising limits—specifically up to Rs 2,000 Crores via a public NCD issue and up to Rs 1,000 Crores via private placement of non-convertible securities in July 2026 ^[10], alongside a completed June 2026 private placement allotment of Rs 325 Crores ^[7] (part of a broader June fundraising aggregating Rs 425 Crores ^[2])—an exact numerical remaining unutilized limit net of all prior historical tranches is not explicitly itemized as a single residual balance in company filings.

---

NCD Issuance Program and Utilization Context

• Board-Approved Limits: On July 24, 2026, the company's Board approved raising up to Rs 2,000 Crores through a public issue of NCDs in multiple tranches and up to Rs 1,000 Crores through private placement of non-convertible securities ^[10].
• Recent Allotments: On June 24, 2026, the Executive, Borrowings & Investment Committee allotted 32,500 senior, secured, rated, listed NCDs aggregating Rs 325 Crores on a private placement basis (carrying a 9.25% fixed coupon maturing June 26, 2028) ^[2]. This followed an additional Rs 100 Crore bilateral NCD placement with Bajaj Finance Limited in June 2026, bringing total June private NCD fundraising to Rs 425 Crores ^[2].
• Disclosure Gap: While gross authorizations are clearly stated at Rs 3,000 Crores combined (public + private) as of July 2026 ^[10], the exact cumulative net unutilized limit remaining under older historical shelf authorizations prior to June 2026 is not separately quantified in the disclosures.

---

Leverage Ratio (Debt/Equity) Comparison

• Notes: †Satin Creditcare's reported percentage figure in KPI data reflects differing ratio scaling conventions in XBRL feeds; peer D/E multipliers are predominantly unquantified in structured quarterly KPI summaries, requiring reliance on standalone equity bases.*

---

Analyst Implications

• Leverage Headroom: CreditAccess Grameen's consolidated D/E ratio of ~3.01x sits within comfortable regulatory capitalization bounds, underpinned by a robust CRAR of 24.87% ^[15] and a net worth exceeding Rs 8,340 Crores ^[9].
• Liability Diversification: The heavy reliance on domestic institutional private placement NCDs (at 9.15% to 9.25% coupons) ^[2] alongside foreign borrowings (accounting for 24% of the liability mix) ^[5] protects the franchise against domestic bank credit growth constraints, though at a higher marginal cost of funds compared to bank term loans.*